Ibritumomab is a murine-derived anti-CD20 monoclonal antibody that kills tumor cells by forming free radicals in target cells and surrounding tissues.Ibritumomab is used in the study of non-Hodgkins lymphoma.
Purity:
98.66%
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted